Stella Talic
Dr Stella Talic, PhD, MSc is an expert in General medicine at Monash University (Australia). Stella Talic has authored 52 publications, the most recent in 2026. SLR score: 230 (community average: 125). How the SLR is computed.
LeadR Profile
General medicine
Subspecialties: Endocrinology - Cardiology - Pharmacy
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2019 - 2026
Number : 52
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Correction: Cardiovascular-Related Polypharmacy and Its Association with Liver and Kidney Function: A Cross-Sectional Study Using Primary Care Data. PMID 42888382 — polypharmacy, cross-sectional studies, kidney, drug therapy, liver | Drugs Aging | 2026 | 0 |
| Opioid Use Is Associated With Lower Health-Related Quality of Life Among Community-Dwelling Older Australians: A Cross-Sectional Study From STAREE. PMID 42853040 — quality of life, cross-sectional studies, aging, analgesia, pharmacoepidemiology | J Am Geriatr Soc | 2026 | 0 |
| Global Burden of Elevated LDL-C: Findings From the Global Burden of Disease Study 2023. PMID 42525403 — myocardial ischemia, heart diseases, cholesterol, ldl, growth, ischemic stroke, stroke, heart, aging, uncertainty, global burden of disease, cost of illness, therapeutics, demography | JAMA Top journal | 2026 | 6 |
| Standardization of measurement and reporting of medication adherence using the TEN-SPIDERS tool for claims data. PMID 42406590 — research design, treatment adherence and compliance, pharmaceutical preparations, pharmacy, pharmacology, medication adherence, research | Br J Clin Pharmacol | 2026 | 1 |
| Shifts in Incident Glucose Lowering Drug Initiation in Type 2 Diabetes From 2014 to 2024: A Population-Based Study. PMID 42373540 — diabetes mellitus, pharmaceutical preparations, therapeutics, metformin, diabetes mellitus, type 2 | Diabetes Obes Metab | 2026 | 0 |
LeadR Networks
Main global connection map